At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹?TP). The ...
Jurek Kozyra, CEO of Nanovery, joins host Karla Jo Helms on the Disruption Interruption podcast to discuss revolutionizing ...
Oxford Nanopore Technologies today announces that the GridIONtm Dx is now both CE and UKCA marked, making it the company's ...
The Independent Medical Alliance (IMA) today announced the release of Volume 2, Issue 1 of the Journal of Independent Medicine—the journal's fifth issue to date and the first issue of its second year ...
Last week, biotechnology company Ascidian Therapeutics announced a manufacturing partnership with gene-therapy–focused ...
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of ExcellenceBOSTON & MILAN--(BUSINESS WIRE)- ...
In a major boost for health research, 22 UQ researchers and teams have secured $29 million from the National Health and ...
The blood-brain and blood-retinal barriers are protective systems that prevent harmful substances from entering the brain and eyes. These barriers are created by cells that are joined tightly together ...
Yesterday we explored four key myths and why they don’t stand up to scrutiny: ‘Vaccines were never properly tested’ ...
Jacksonville Journal-Courier on MSNOpinion
Commentary: We can’t ‘true crime’ way to fairer courts — Yaël Ossowski
Commentary: If the true crime phenomenon has proven anything, it’s that courtrooms and science don’t mix well.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback